Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
35 kDa Hyaluronan Fragment for Pain in Advanced Lung Cancer
NCT05852002Completed
- Sponsor
- Nakhia Impex LLC
- Start
- Apr 2023
- Primary completion
- Nov 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of ha35 in non-small cell lung cancer (NSCLC), sponsored by Nakhia Impex LLC. Primary endpoints: Pain scale at 28 days, Respiratory symptom cough at 28 days and 3 more. Started Apr 2023; status: completed.
02
Drugs
ha35
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05852002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05852002.